These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 29360952

  • 1. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Lambert M, Boet A, Rucker-Martin C, Mendes-Ferreira P, Capuano V, Hatem S, Adão R, Brás-Silva C, Hautefort A, Michel JB, Dorfmuller P, Fadel E, Kotsimbos T, Price L, Jourdon P, Montani D, Humbert M, Perros F, Antigny F.
    Cardiovasc Res; 2018 May 01; 114(6):880-893. PubMed ID: 29360952
    [Abstract] [Full Text] [Related]

  • 2. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F, Hautefort A, Meloche J, Belacel-Ouari M, Manoury B, Rucker-Martin C, Péchoux C, Potus F, Nadeau V, Tremblay E, Ruffenach G, Bourgeois A, Dorfmüller P, Breuils-Bonnet S, Fadel E, Ranchoux B, Jourdon P, Girerd B, Montani D, Provencher S, Bonnet S, Simonneau G, Humbert M, Perros F.
    Circulation; 2016 Apr 05; 133(14):1371-85. PubMed ID: 26912814
    [Abstract] [Full Text] [Related]

  • 3. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW, Tian L, Wu D, Thenappan T, Metzger JM, Archer SL.
    J Am Heart Assoc; 2017 May 31; 6(6):. PubMed ID: 28566298
    [Abstract] [Full Text] [Related]

  • 4. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM, Chaudhary KR, Deng Y, Jiang B, Stewart DJ.
    Cardiovasc Res; 2019 Mar 15; 115(4):788-799. PubMed ID: 30357319
    [Abstract] [Full Text] [Related]

  • 5. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.
    Lambert M, Mendes-Ferreira P, Ghigna MR, LeRibeuz H, Adão R, Boet A, Capuano V, Rucker-Martin C, Brás-Silva C, Quarck R, Domergue V, Vachiéry JL, Humbert M, Perros F, Montani D, Antigny F.
    Cardiovasc Res; 2021 Nov 01; 117(12):2474-2488. PubMed ID: 33483721
    [Abstract] [Full Text] [Related]

  • 6. Distinct right ventricle remodeling in response to pressure overload in the rat.
    Mendes-Ferreira P, Santos-Ribeiro D, Adão R, Maia-Rocha C, Mendes-Ferreira M, Sousa-Mendes C, Leite-Moreira AF, Brás-Silva C.
    Am J Physiol Heart Circ Physiol; 2016 Jul 01; 311(1):H85-95. PubMed ID: 27199115
    [Abstract] [Full Text] [Related]

  • 7. Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension.
    Lambert M, Capuano V, Boet A, Tesson L, Bertero T, Nakhleh MK, Remy S, Anegon I, Pechoux C, Hautefort A, Rucker-Martin C, Manoury B, Domergue V, Mercier O, Girerd B, Montani D, Perros F, Humbert M, Antigny F.
    Circ Res; 2019 Sep 13; 125(7):678-695. PubMed ID: 31347976
    [Abstract] [Full Text] [Related]

  • 8. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R, Mendes-Ferreira P, Santos-Ribeiro D, Maia-Rocha C, Pimentel LD, Monteiro-Pinto C, Mulvaney EP, Reid HM, Kinsella BT, Potus F, Breuils-Bonnet S, Rademaker MT, Provencher S, Bonnet S, Leite-Moreira AF, Brás-Silva C.
    Cardiovasc Res; 2018 Jul 01; 114(8):1165-1177. PubMed ID: 29584808
    [Abstract] [Full Text] [Related]

  • 9. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM, Mik EG, Eerbeek O, Specht PA, van der Laarse WJ, Zuurbier CJ.
    Respir Res; 2015 Feb 03; 16(1):6. PubMed ID: 25645252
    [Abstract] [Full Text] [Related]

  • 10. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M, Sala L, Rizzetto R, Staszewsky LI, Alemanni M, Zambelli V, Russo I, Barile L, Cornaghi L, Altomare C, Ronchi C, Mostacciuolo G, Lucchetti J, Gobbi M, Latini R, Zaza A.
    Cardiovasc Res; 2014 Oct 01; 104(1):37-48. PubMed ID: 25139747
    [Abstract] [Full Text] [Related]

  • 11. The Impact of Heterozygous KCNK3 Mutations Associated With Pulmonary Arterial Hypertension on Channel Function and Pharmacological Recovery.
    Bohnen MS, Roman-Campos D, Terrenoire C, Jnani J, Sampson KJ, Chung WK, Kass RS.
    J Am Heart Assoc; 2017 Sep 09; 6(9):. PubMed ID: 28889099
    [Abstract] [Full Text] [Related]

  • 12. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Nguyen QT, Nsaibia MJ, Sirois MG, Calderone A, Tardif JC, Fen Shi Y, Ruiz M, Daneault C, Gagnon L, Grouix B, Laurin P, Dupuis J.
    Cardiovasc Res; 2020 Jan 01; 116(1):171-182. PubMed ID: 30753422
    [Abstract] [Full Text] [Related]

  • 13. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A, Mendes-Ferreira P, Sabourin J, Manaud G, Bertero T, Rucker-Martin C, Riou M, Adão R, Manoury B, Lambert M, Boet A, Lecerf F, Domergue V, Brás-Silva C, Gomez AM, Montani D, Girerd B, Humbert M, Antigny F, Perros F.
    Circulation; 2019 Feb 12; 139(7):932-948. PubMed ID: 30586714
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.
    Baptista R, Marques C, Catarino S, Enguita FJ, Costa MC, Matafome P, Zuzarte M, Castro G, Reis A, Monteiro P, Pêgo M, Pereira P, Girão H.
    Cardiovasc Res; 2018 Jan 01; 114(1):53-64. PubMed ID: 29016730
    [Abstract] [Full Text] [Related]

  • 15. Ca2+ handling remodeling and STIM1L/Orai1/TRPC1/TRPC4 upregulation in monocrotaline-induced right ventricular hypertrophy.
    Sabourin J, Boet A, Rucker-Martin C, Lambert M, Gomez AM, Benitah JP, Perros F, Humbert M, Antigny F.
    J Mol Cell Cardiol; 2018 May 01; 118():208-224. PubMed ID: 29634917
    [Abstract] [Full Text] [Related]

  • 16. Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension.
    Kwan ED, Hardie BA, Garcia KM, Mu H, Wang TM, Valdez-Jasso D.
    Am J Physiol Heart Circ Physiol; 2024 Aug 01; 327(2):H351-H363. PubMed ID: 38847755
    [Abstract] [Full Text] [Related]

  • 17. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
    Xie YP, Chen B, Sanders P, Guo A, Li Y, Zimmerman K, Wang LC, Weiss RM, Grumbach IM, Anderson ME, Song LS.
    Hypertension; 2012 Feb 01; 59(2):355-62. PubMed ID: 22203744
    [Abstract] [Full Text] [Related]

  • 18. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A.
    Am J Physiol Heart Circ Physiol; 2009 Nov 01; 297(5):H1606-16. PubMed ID: 19783775
    [Abstract] [Full Text] [Related]

  • 19. Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function.
    Santos-Gomes J, Mendes-Ferreira P, Adão R, Maia-Rocha C, Rego B, Poels M, Saint-Martin Willer A, Masson B, Provencher S, Bonnet S, Montani D, Perros F, Antigny F, Leite-Moreira AF, Brás-Silva C.
    Int J Mol Sci; 2024 Jul 24; 25(15):. PubMed ID: 39125620
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG, Hacker TA, Schreier DA, Chesler NC, Wang Z.
    Am J Physiol Heart Circ Physiol; 2019 May 01; 316(5):H1005-H1013. PubMed ID: 30822119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.